Madrigal Pharmaceuticals Inc (MDGL)

08:41 AM

Madrigal Pharmaceuticals Inc. Stock Analysis and ForecastSkyrocketing investment returns - Autocar Professional

08:41 AM

08:17 AM

Madrigal Pharmaceuticals to Release Second-Quarter 2025 Financia - GuruFocus

08:17 AM

08:15 AM

Madrigal Pharmaceuticals, Inc. Announces Second-Quarter 2025 Financial Results Release and Webcast Details - Quiver Quantitative

08:15 AM

08:01 AM

Madrigal Pharmaceuticals to Release Second-Quarter 2025 Financial Results and Host Webcast on August 5, 2025 - GlobeNewswire

08:01 AM

08:00 AM

Madrigal Pharmaceuticals to Release Second-Quarter 2025 Financial Results and Host Webcast on August 5, 2025 - GlobeNewswire Inc.

08:00 AM

Jul 24, 2025

Madrigal (MDGL) Secures $500M to Fuel MASH Pipeline Expansion - Insider Monkey

Jul 24, 2025

Jul 24, 2025

Madrigal Pharmaceuticals Secures $500 Million Credit Facility to Expand MASH Pipeline - MSN

Jul 24, 2025

Jul 24, 2025

Madrigal Pharmaceuticals: Strengthened Financial Position and Promising Pipeline Expansion Drive Buy Rating - TipRanks

Jul 24, 2025

Jul 23, 2025

Madrigal Pharmaceuticals secures $500M credit facility from Blue Owl - MSN

Jul 23, 2025

Jul 23, 2025

Madrigal Pharmaceuticals: Strategic Financing and Growth Potential Justify Buy Rating - TipRanks

Jul 23, 2025

Jul 23, 2025

What drives Madrigal Pharmaceuticals Inc. stock priceHigh-velocity gains - Autocar Professional

Jul 23, 2025

Jul 22, 2025

Is Madrigal Pharmaceuticals Inc. a good long term investmentHigh-profit trading signals - jammulinksnews.com

Jul 22, 2025

Jul 22, 2025

What analysts say about Madrigal Pharmaceuticals Inc. stockSuperior portfolio returns - jammulinksnews.com

Jul 22, 2025

Jul 22, 2025

Madrigal Pharmaceuticals Secures $500 Million in Senior - GlobeNewswire

Jul 22, 2025

Jul 22, 2025

Madrigal's $500M Financing: Cementing Leadership in the High-Growth MASH Market - AInvest

Jul 22, 2025

Jul 22, 2025

Madrigal Pharmaceuticals Secures $500M Credit Facility - TipRanks

Jul 22, 2025

Jul 22, 2025

Madrigal Pharmaceuticals (MDGL) Secures $500 Million Credit Facility - GuruFocus

Jul 22, 2025

Jul 22, 2025

Madrigal Pharmaceuticals Secures $500 Million in Senior Secured - GuruFocus

Jul 22, 2025

Jul 22, 2025

Madrigal secures $500 million credit facility to advance MASH pipeline By Investing.com - Investing.com Nigeria

Jul 22, 2025

Jul 22, 2025

Madrigal Pharmaceuticals Secures $500 Million Senior Secured Credit Facility to Enhance MASH Pipeline and Support Strategic Expansion - Quiver Quantitative

Jul 22, 2025

Jul 22, 2025

Citizens JMP reiterates Madrigal stock rating on strong Rezdiffra uptake By Investing.com - Investing.com Canada

Jul 22, 2025

Jul 21, 2025

10 Most Undervalued Healthcare Stocks to Buy According to Analysts - Insider Monkey

Jul 21, 2025

Jul 20, 2025

Madrigal Pharmaceuticals shares surge after extended patent protection for MASH therapy - MSN

Jul 20, 2025

Jul 19, 2025

Madrigal Pharmaceuticals Secures Key Patent for Rezdiffra, Extending Market Protection to 2044 - MSN

Jul 19, 2025

Jul 19, 2025

Madrigal gains after Rezdiffra patent win - MSN

Jul 19, 2025

Jul 19, 2025

MDGL Stock Soars 11% on New Patent Protecting Rezdiffra Dosing Rights - MSN

Jul 19, 2025

Jul 19, 2025

Madrigal Pharmaceuticals Grants Equity Awards to 30 New Team Members - MSN

Jul 19, 2025

Jul 17, 2025

Madrigal (MDGL) Moves 10.9% Higher: Will This Strength Last? - Yahoo Finance

Jul 17, 2025

Jul 17, 2025

Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire

Jul 17, 2025

Jul 17, 2025

When (MDGL) Moves Investors should Listen - news.stocktradersdaily.com

Jul 17, 2025

Jul 16, 2025

Madrigal Pharmaceuticals receives notice of allowance for Rezdiffra patent - TipRanks

Jul 16, 2025

Jul 16, 2025

Madrigal Pharmaceuticals Surges to 222nd in Daily Rankings with $451 Million Turnover - AInvest

Jul 16, 2025

Jul 16, 2025

Madrigal Pharmaceuticals: Strong Surge or Overpriced? - StocksToTrade

Jul 16, 2025

Jul 16, 2025

Madrigal Pharmaceuticals stock price target raised by Oppenheimer on patent news - Investing.com Canada

Jul 16, 2025

Jul 16, 2025

Madrigal’s Surge: Breakthrough in Liver Treatment? - timothysykes.com

Jul 16, 2025

Jul 16, 2025

Madrigal Pharmaceuticals Soars: Is It Time to Buy?​ - StocksToTrade

Jul 16, 2025

Jul 16, 2025

Madrigal Pharmaceuticals (MDGL) Surges Over 12% in Market Gains - GuruFocus

Jul 16, 2025

Jul 16, 2025

Madrigal Pharmaceuticals (MDGL) Soars on Rezdiffra Patent Approval - GuruFocus

Jul 16, 2025

Jul 16, 2025

Madrigal gains after Rezdiffra patent win (MDGL:NASDAQ) - Seeking Alpha

Jul 16, 2025

Jul 16, 2025

Madrigal stock jumps as patent protection for MASH treatment extended By Investing.com - Investing.com Nigeria

Jul 16, 2025

Jul 16, 2025

Madrigal stock jumps as patent protection for MASH treatment extended - Investing.com

Jul 16, 2025